Skip to main content

Table 10 Outcomes predicted by models for one birth cohort in Eur-region

From: Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

  POLYMODa Roxanne CoRoVa
Undiscounted cases    
   Mild 22,708 32,186 28,680
   Moderate 10,360 14,580 10,430
   Severe 1,658 2,324 1,806
   Nosocomial 415 528 452
   Deaths 1 1 1
   GP-visits 12,019 14,580 10,430
   Inpatient (comm. acq.) 1,658 2,324 1,860
Discounted savings    
   Outpatient €480,745 €556,984 €829,111
   Inpatient €4,643,286 €5,949,119 €4,714,920
   Indirect € 1,322,021 € 2,111,857 € 2,088,993
Discounted net costs b € 9,032,932 € 9,842,807 € 9,518,208
Discounted QALYs    
   Mortality 25 27 26
   Morbidity 131 166 142
  1. a. Approximations for one cohort from the multi-cohort results; b. Health-care perspective.